BFLY vs NNOX vs PHG Stock Comparison

Butterfly Network, Nano-X Imaging and Koninklijke Philips Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (LNTH) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$7.51 -17.5% 1M +249.3% 1Y
Market cap
$1.67B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
NNOX Nano-X Imaging Ltd.
$0.31 -53.0% 1M -91.7% 1Y
Market cap
$21.26M
P/E
–
Revenue (TTM)
$15.63M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
PHG Koninklijke Philips Nv
$27.13 +9.5% 1M -1.7% 1Y
Market cap
$25.54B
P/E
13.9x
Revenue (TTM)
$20.60B
Div. yield
–
Diagnostic Equipment Healthcare
5 wins

Head to Head

9 decided of 12

Koninklijke Philips leads on 5 of the 12 questions below (Koninklijke Philips 5, Butterfly Network 3, Nano-X Imaging 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYNNOXPHGLeader
Larger companyMarket capitalisation $1.67B $21.26M $25.54B PHG
Cheaper on earningsLower P/E, profitable companies only -31.1x -0.2x 13.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 13.7x –
Faster revenue growthRevenue growth, trailing twelve months +39.4% +31.5% +6.1% BFLY
More profitableNet margin, trailing twelve months — -747.2% 8.9% PHG
Better return on capitalReturn on invested capital — -116.9% 11.5% PHG
Less leveragedLower net debt / EBITDA — 0.3x 1.8x NNOX
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +249.3% -91.7% -1.7% BFLY
Better 5-year returnAnnualised price return, 5 years -6.2%/yr -57.6%/yr -10.5%/yr BFLY
Less volatileAnnualised volatility, 1 year 115.0% 105.8% 28.3% PHG
Higher overall scoreMean of the five percentile scores vs peers 47/100 36/100 81/100 PHG

Percentile Scorecard

BFLYNNOXPHG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYNNOXPHG
Valuation 21 #179 of 227 52 #110 of 227 98 #6 of 227
Growth 90 #23 of 218 10 #196 of 218 96 #9 of 218
Profitability 29 #144 of 202 10 #182 of 202 96 #10 of 202
Financial Health – 70 #70 of 233 33 #156 of 233
Shareholder Returns – – 81 #26 of 130
Overall 47 36 81
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • NNOX ranked among 247 companies in Medical Devices and Diagnostics
  • PHG ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYNNOXPHGSPY
1 month -17.5%-53.0%+9.5% +0.7%
3 months -8.0%-67.7%+2.6% +3.7%
6 months +56.8%-81.9%+3.0% +7.1%
Year to date +97.6%-88.9%+0.2% +12.8%
1 year +249.3%-91.7%-1.7% +11.9%
3 years +827.2%-93.8%+45.8% +85.2%
3 years, per year +110.2%-60.4%+13.4% +22.8%
5 years -27.2%-98.6%-42.6% +67.6%
5 years, per year -6.2%-57.6%-10.5% +10.9%
10 years ——-10.1% +262.0%
10 years, per year ——-1.1% +13.7%

Risk

MeasureBFLYNNOXPHGSPY
Volatility, 1Y 115.0%105.8%28.3% 12.7%
Downside volatility, 1Y 91.8%116.5%27.7% 12.6%
Beta vs S&P 500, 1Y 3.021.370.82 1.00
Return / volatility, 1Y 2.17-0.87-0.06 0.94
Max drawdown, 5Y -93.4%-98.9%-75.6% -25.4%
From 52-week high -24.4%-93.2%-17.6% -1.2%
52-week high $9.94$4.55$32.91 $779.14
52-week low $1.97$0.31$23.81 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYNNOXPHG
P/E now vs peer median -36.7xmedian 28.7x -0.2xmedian 28.7x 14.0xmedian 28.7x
P/S now vs peer median 14.5xmedian 3.0x 1.4xmedian 3.0x 1.3xmedian 3.0x
EV/EBITDA now vs peer median —median 17.8x 0.1xmedian 17.8x 8.2xmedian 17.8x
P/FCF now vs peer median -77.2xmedian 26.4x -0.4xmedian 26.4x 6.0xmedian 26.4x
P/B now vs peer median 9.7xmedian 2.4x 0.3xmedian 2.4x 2.0xmedian 2.4x
PEG now vs peer median -1.22median 0.99 -0.07median 0.99 0.33median 0.99

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYNNOXPHG
Revenue $123.25M $15.63M $20.60B
Gross profit $86.60M -$52.76M $16.03B
Operating income -$57.83M -$119.69M $2.65B
Net income -$53.69M -$116.81M $1.39B
Free cash flow – -$52.09M $4.34B
R&D $39.57M $18.93M $2.00B
EPS (diluted) $-0.20 $-1.80 $1.91
Cash & equivalents $122.30M $31.02M $2.04B
Total debt – $3.00M $9.51B
Shares (diluted) 262.10M 64.79M 962.50M
Enterprise value $1.67B -$158.42M $14.65B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYNNOXPHG
P/E -36.7x -0.2x 14.0x
P/FCF -77.2x -0.4x 6.0x
P/Operating cash flow -76.4x -0.5x 9.8x
P/S 14.5x 1.4x 1.3x
P/B 9.7x 0.3x 2.0x
P/Tangible book 10.0x 0.4x 2.6x
EV/EBITDA – 0.1x 8.2x
EV/EBIT – 0.1x 12.6x
EV/Revenue 14.5x -0.4x 1.6x
EV/FCF – 0.1x 7.7x
EV/Operating cash flow -76.4x 0.1x 12.6x
PEG (3Y EPS CAGR) -1.22 -0.07 0.33

Growth

14 metrics
MetricBFLYNNOXPHG
Revenue growth (1Y) 39.4% 31.5% 6.1%
Revenue CAGR (3Y) 21.7% 17.7% 2.3%
Gross profit growth (1Y) 126.4% -340.0% 82.4%
Gross profit CAGR (3Y) 30.5% -101.8% 6.7%
Operating income growth (1Y) 33.5% -107.4% 121.3%
Operating income CAGR (3Y) 26.9% -5.0% 52.0%
Net income growth (1Y) 32.8% -109.9% 293.5%
Net income CAGR (3Y) 24.2% -4.9% 35.6%
EPS growth (1Y) 35.4% -90.0% 539.4%
EPS CAGR (3Y) 30.0% 2.3% 42.2%
Operating cash flow growth (1Y) 5.8% -21.9% 116.7%
Operating cash flow CAGR (3Y) 41.1% -2.7% 53.6%
Free cash flow growth (1Y) – -19.4% 54.2%
Free cash flow CAGR (3Y) – 1.3% 45.6%

Profitability

14 metrics
MetricBFLYNNOXPHG
Gross margin – -337.5% 77.8%
EBITDA margin – -692.4% 19.8%
Operating margin – -765.6% 12.9%
Pretax margin – -758.5% 11.9%
Net margin – -747.2% 8.9%
FCF margin – -333.2% 21.1%
Operating cash flow margin -19.0% -298.7% 12.9%
Return on equity – -117.5% 12.7%
Return on assets – -98.6% 5.4%
Return on invested capital – -116.9% 11.5%
Return on capital employed – -114.2% 11.8%
Asset turnover 0.4x 0.1x 0.7x
Cash conversion (OCF / net income) 0.4x 0.4x 1.9x
Stock comp / revenue 20.8% 34.9% 0.7%

Financial Health

11 metrics
MetricBFLYNNOXPHG
Debt / assets – 3.3% 31.2%
Debt / equity – 0.0x 0.7x
Net debt / EBITDA – 0.3x 1.8x
Debt / FCF – -0.1x 2.2x
Liabilities / assets 36.0% 20.5% 57.1%
Equity / assets 64.0% 79.5% 42.9%
Interest coverage – – 6.2x
Current ratio – 2.8x 1.3x
Quick ratio – 2.4x 0.7x
Cash ratio – 2.3x 0.2x
Altman Z-score – -11.10 –

Shareholder Returns

7 metrics
MetricBFLYNNOXPHG
Dividend yield – – 3.6%
Net buyback yield – – -0.5%
Shareholder yield – – 3.2%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYNNOXPHG
Forward P/E – – 13.7xFY2026
EPS, next fiscal year $-0.10FY2026 $-1.31FY2026 $1.98FY2026
EPS growth, next FY – – +6.5%FY2026
EPS growth, the year after – – -10.1%
Revenue, next fiscal year $114.50MFY2026 $18.64MFY2026 $21.63BFY2026
Revenue growth, next FY +17.3%FY2026 +43.2%FY2026 +1.8%FY2026
Revenue growth, the year after +26.0% +59.6% -8.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYNNOXPHG
Held by institutions 59.9% 14.9% 5.4%
Institutions holding 246 102 364
Change in shares held, QoQ +13.9% -46.0% +0.8%
Institutions buying 143 55 267
Institutions selling 59 28 76
Buyers to sellers 2.42 1.96 3.51

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYNNOXPHG
BFLY 1.00 0.16 0.21
NNOX 0.16 1.00 0.08
PHG 0.21 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, NNOX and PHG?

Koninklijke Philips (PHG) is the largest by market capitalisation: Butterfly Network (BFLY) $1.67B, Nano-X Imaging (NNOX) $21.26M, Koninklijke Philips (PHG) $25.54B.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Nano-X Imaging (NNOX) +31.5%, Koninklijke Philips (PHG) +6.1%.

Which company is more profitable?

Koninklijke Philips (PHG) has the highest net margin (Nano-X Imaging (NNOX) -747.2%, Koninklijke Philips (PHG) 8.9%). On return on invested capital, Koninklijke Philips (PHG) leads (Nano-X Imaging (NNOX) -116.9%, Koninklijke Philips (PHG) 11.5%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +249.3%, Nano-X Imaging (NNOX) -91.7%, Koninklijke Philips (PHG) -1.7%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -6.2%/yr, Nano-X Imaging (NNOX) -57.6%/yr, Koninklijke Philips (PHG) -10.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Butterfly Network (BFLY) 115.0%, Nano-X Imaging (NNOX) 105.8%, Koninklijke Philips (PHG) 28.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, NNOX and PHG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.